<DOC>
	<DOCNO>NCT01241110</DOCNO>
	<brief_summary>Objective : To compare two oral treatment : Ofloxacin + Metronidazole , Azitromycin +Metronidazole outpatient Pelvic Inflammatory Disease . Materials Methods : Two hundred patient divide two group ( A , B ) . Group A ( treat Ofloxacin 400 mg. + Metronidazole 500mg ) Group B ( single dose oral Azitromicine 1gr + Metronidazole 500mg ) 10 day , compare term side effect efficacy</brief_summary>
	<brief_title>To Compare Ofloxacin With Azitromycin Pelvic Inflammatory Disease ( PID ) Treatment</brief_title>
	<detailed_description>Two hundred patient divide two group ( A , B ) . Group A ( treat Ofloxacin 400 mg. + Metronidazole 500mg ) Group B ( single dose oral Azitromicine 1gr + Metronidazole 500mg ) 10 day , compare term side effect efficacy</detailed_description>
	<mesh_term>Pelvic Inflammatory Disease</mesh_term>
	<mesh_term>Pelvic Infection</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<criteria>Eligibility criterion three five follow symptom : alower abdominal pain , bvaginal discharge , c adnexal tenderness , dcervical motion tenderness ( CMT ) , ecervisitis . Excluding criterion follow : aunmarried woman , bpregnant woman , cwomen infection menstruation , history abortion miscarriage last month , eunderlying disease diabetes , fuse antibiotic last month , allergy antibiotic use study , ghistory Pelvic Inflammatory Disease within last year , h suspicion multi partner .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>PID , Ofloxacin , Azitromicine , Metronidazole</keyword>
</DOC>